[HTML][HTML] The potential role of dyslipidemia in COVID-19 severity: an umbrella review of systematic reviews

GJ Choi, HM Kim, H Kang - Journal of Lipid and Atherosclerosis, 2020 - ncbi.nlm.nih.gov
Objective The aim of this study was to analyze the available knowledge about the potential
association between dyslipidemia and the severity of coronavirus disease 2019 (COVID-19) …

Kidney disease in HIV infection

G Alfano, G Cappelli, F Fontana, L Di Lullo… - Journal of clinical …, 2019 - mdpi.com
Antiretroviral therapy (ART) has significantly improved life expectancy of infected subjects,
generating a new epidemiological setting of people aging withHuman Immunodeficiency …

Statin therapy in COVID-19 infection

V Castiglione, M Chiriacò, M Emdin… - European Heart …, 2020 - academic.oup.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of the
current pandemic of coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a positive …

Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review

Y Sharifi, M Payab, E Mohammadi-Vajari… - Journal of Diabetes & …, 2021 - Springer
The novel coronavirus, which began spreading from China Wuhan and gradually spreaded
to most countries, led to the announcement by the World Health Organization on March 11 …

[HTML][HTML] TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disorders

PM Cevaal, LG Bekker, S Hermans - Tuberculosis, 2019 - Elsevier
In almost one in five HIV/tuberculosis (TB) co-infected patients, initiation of antiretroviral
therapy (ART) is complicated by TB immune reconstitution inflammatory syndrome (TB-IRIS) …

Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives

PC Fragkou, CD Moschopoulos, D Dimopoulou… - Hellenic Journal of …, 2023 - Elsevier
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor,
and the cumulative cardiovascular disease (CVD) burden among aging people living with …

Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21

S Elahi, RH Weiss, S Merani - Aids, 2016 - journals.lww.com
Objective: Antigen persistence due to HIV is a major source of inflammation and substantial
immune activation, both of which are linked to accelerated aging. This illustrates the need to …

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol

JP Routy, S Isnard, V Mehraj, M Ostrowski… - BMJ open, 2019 - bmjopen.bmj.com
Introduction People living with HIV (PLWH) on antiretroviral therapy (ART) do not progress to
AIDS. However, they still suffer from an increased risk of inflammation-associated …

Atherosclerosis in HIV patients: what do we know so far?

AV Poznyak, EE Bezsonov, EE Borisov… - International Journal of …, 2022 - mdpi.com
For the past several decades, humanity has been dealing with HIV. This disease is one of
the biggest global health problems. Fortunately, modern antiretroviral therapy allows …

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a …

S Srichatrapimuk, A Wongsa, S Sungkanuparph… - AIDS Research and …, 2023 - Springer
Background Chronic inflammation has been described in people living with HIV (PLHIV)
receiving antiretroviral therapy (ART) despite viral suppression. Inflammation associated …